Lasers in Surgery and Medicine Journal Publishes Peer-Reviewed Paper Confirming Safety and Efficacy of TriPollar RF Technology.
Tel Aviv, Israel (PRWEB) July 17, 2012
Co-authored by Steven D. Shapiro, M.D. of Gardens Dermatology and Cosmetic Surgery Center in Florida, U.S. and Dr. Amos Leviav of Kaplan Hospital Plastic Surgery Department in Rehovot, Israel, “Evaluation of Safety and Efficacy of the TriPollar Technology for Treatment of Wrinkles” appears in Lasers in Surgery and Medicine Journal and reviews a clinical study of Pollogen’s Apollo system. The paper is available at http://onlinelibrary.wiley.com/doi/10.1002/lsm.22044/abstract.
The blinded clinical trial involved 37 female subjects who received eight weekly TriPollar treatments via a device called TriPollar Apollo for the reduction of facial wrinkles. Subjects were scheduled for follow-up visits at one and three months following their last treatment. There were no unexpected adverse side effects, and 100% of the patients reported virtually painless treatment and were satisfied from treatment results. Photographic analysis of pre- and post-treatment by two physicians revealed improvement of 94%-97%.
“I am pleased to be the first to work with TriPollar RF technology in the U.S.,” stated Dr. Shapiro, principle investigator of the clinical trial. “We performed 136 treatments in our study without any side effects. Patients reported a pleasant and pain-free experience and were satisfied with the results. I observed a significant reduction in wrinkles and overall, I am impressed by the immediate and long-term results achieved with the TriPollar technology and its strong safety profile.”
Although the TriPollar Apollo is FDA-cleared for the non-invasive treatment of mild to moderate facial wrinkles, the 30-minute, no-downtime procedure is also CE-approved for circumferential reduction and the reduction of cellulite. These currently off-label non-invasive body contouring applications have become the treatment of choice internationally. Unlike its competitors, the TriPollar Apollo provides a painless and pleasant treatment, is effective on all skin types and allows immediate and measurable long-term anti-aging results.
“As global leaders, we are committed to developing the most innovative, non-invasive anti-aging products that improve the well being of our patients worldwide,” said Amichai Bar Nir, CEO of Pollogen. “TriPollar treatments have been available for over six years in Europe and Asia. Recently FDA-cleared in the United States, patients are increasingly opting for the convenient and effective treatment that TriPollar offers.”
More about TriPollar RF Technologies:
Click here to view a webinar led by Dr. Steven Shapiro discussing Safety and Efficacy of TriPollar Technology for Wrinkles.
View Dr. Shapiro demonstrating TriPollar RF and conducting Q&A session.
Pollogen Ltd. is a global leader in the medical aesthetic market, providing professionals in over 60 countries with a wide variety of advanced aesthetic solutions to best serve their customers. Pollogen is the developer and manufacturer of three revolutionary technologies under the industry premier brand names TriPollar®, TriLipo® and TriFractional™ and offers a full line of clinically-proven, safe and effective, non-invasive anti-aging facial and body contouring treatment platforms for a range of aesthetic applications including circumference reduction, cellulite reduction and skin tightening. For more information, visit http://www.pollogen.com.
Pollogen—Expect More: More Innovation, More Results, More Service.
Read the full story at http://www.prweb.com/releases/tripollar/peerreview/prweb9693595.htm